PDL BioPharma to Participate at H.C. Wainwright & Co. Global Life Sciences Conference

PRNewswire 26-Mar-2019 9:00 AM

INCLINE VILLAGE, Nev., March 26, 2019 /PRNewswire/ -- PDL BioPharma, Inc. ("PDL" or the "Company") (NASDAQ:PDLI) announces that Dominique Monnet, PDL's president and chief executive officer, and Peter Garcia, PDL's chief financial officer, will present at the H.C. Wainwright & Co. Global Life Sciences Conference in London.  The session will be webcast live and will occur on Tuesday, April 9, 2019, at 10:50 a.m. British Standard Time. 

To access the live and subsequently archived webcast of the presentation, visit the Company's website at https://www.pdl.com/, go to the Investor Relations section and select "Events & Presentations."  Please connect to the website at least 15 minutes prior to the presentation to allow for any software download that may be necessary.  The archived webcast will be available for at least seven days following the presentation. 

About PDL BioPharma, Inc.
PDL BioPharma seeks to provide a significant return for its stockholders by acquiring commercial stage pharmaceutical assets with multiple year revenue growth potential as well as late clinical stage pharmaceutical products.  For more information please visit www.pdl.com.

NOTE:  PDL, PDL BioPharma, the PDL logo and the PDL BioPharma logo are trademarks or registered trademarks of, and are proprietary, to PDL BioPharma, Inc. which reserves all rights therein.

View original content to download multimedia:http://www.prnewswire.com/news-releases/pdl-biopharma-to-participate-at-hc-wainwright--co-global-life-sciences-conference-300818422.html

SOURCE PDL BioPharma, Inc.